Delivery Order SPE2DB24D3014-SPE2DB25FKTFC
- Not listed
- The Defense Logistics Agency awarded a $25,207.11 delivery order to AmerisourceBergen Drug Corp for ENBREL 50 mg/ml SureClick auto-injectors, with an ultimate completion date of June 26, 2025. This non-set-aside, competitively awarded contract employs firm fixed price terms and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a $7,588.49 delivery order to AmerisourceBergen Drug Corp for ENBREL 50 mg/mL SureClick auto-injectors, with performance in Conshohocken, Pennsylvania and completion targeted for August 26, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting...
- The Defense Logistics Agency (DLA) awarded a $4,665.44 delivery order to AmerisourceBergen Drug Corp for Enbrel 50 mg/mL SureClick auto-injectors on August 1, 2025, with an ultimate completion date of August 4, 2025. This competitively awarded, firm fixed-price contract reflects no set-aside designation and is being performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $100,829.77 delivery order to AmerisourceBergen Drug Corp for ENBREL 50 mg/mL SureClick auto-injectors, with a firm fixed price and an ultimate completion date of September 4, 2025. This non-set-aside, competitively awarded contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The delivery will be performed at the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $35,552.50 to AmerisourceBergen Drug Corp for the supply of ENBREL 50 mg/mL SureClick auto-injectors. The contract, awarded on April 21, 2025, with an ultimate completion date of April 22, 2025, represents a firm fixed-price delivery order with no set-aside designation. Performance will be conducted at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued...
- The Defense Logistics Agency awarded a delivery order valued at $9,253.56 to AmerisourceBergen Drug Corp for ENBREL 50 mg/mL SureClick auto-injectors, with a completion date of July 15, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency (DLA) awarded a $20,188.16 delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Enbrel 50 mg/mL SureClick auto-injectors. This is a firm fixed price, non-set-aside contract with a place of performance in Conshohocken, Pennsylvania, and an ultimate completion date of August 6, 2025. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for ENBREL 50 MG/ML SureClick auto-injectors valued at $9,253.56 on July 30, 2025, with a completion date of July 31, 2025. This firm fixed price, non-competitive delivery order represents pharmaceutical procurement for military healthcare needs and is being fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, the company's corporate headquarters. This delivery order is...
- The Defense Logistics Agency awarded a $122,324.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ENBREL 50 MG/ML SureClick auto-injector pharmaceutical products, with an ultimate completion date of July 29, 2025. This non-set-aside competitive award was issued on July 28, 2025, for delivery to the company's corporate office location in Conshohocken, Pennsylvania. The delivery order is executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency (DLA) awarded a $18,582.22 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ENBREL 50 mg/mL SureClick auto-injectors, with performance in Conshohocken, Pennsylvania and an ultimate completion date of August 28, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor vehicle valued...
- SPE2DB24D3014Indefinite Delivery Contract
- SPE2DB24D3014-SPE2DB25FKTFCDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,626.77 to AmerisourceBergen Drug Corp for ENBREL 50 mg/ml SureClick auto-injectors, with performance in Conshohocken, Pennsylvania. This competitively awarded, firm fixed-price contract, issued on April 22, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The delivery order carries no set-aside designation and is scheduled for completion by April 23, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal military and veteran healthcare procurement through its prime IDC vehicle. The SPE2DX contract functions as a comprehensive global pharmaceutical support platform enabling the company to supply a broad range of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic areas to support military healthcare programs worldwide. This delivery order for ENBREL, a specialty rheumatoid arthritis treatment, exemplifies the company's role in fulfilling specialized pharmaceutical needs for the Defense Health Agency and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.6k | 4/22/25 |